Share This Page
Drug Price Trends for ANTACID EX-STR
✉ Email this page to a colleague
Average Pharmacy Cost for ANTACID EX-STR
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ANTACID EX-STR 750 MG TAB CHEW | 70000-0681-01 | 0.03219 | EACH | 2025-06-18 |
| ANTACID EX-STR 750 MG TAB CHEW | 70000-0682-01 | 0.03219 | EACH | 2025-06-18 |
| ANTACID EX-STR 750 MG TAB CHEW | 00536-1229-22 | 0.03219 | EACH | 2025-06-18 |
| ANTACID EX-STR 750 MG TAB CHEW | 70000-0592-01 | 0.03219 | EACH | 2025-06-18 |
| ANTACID EX-STR TABLET CHEW | 70000-0234-01 | 0.04146 | EACH | 2025-06-18 |
| ANTACID EX-STR 750 MG TAB CHEW | 70000-0430-02 | 0.03219 | EACH | 2025-06-18 |
| ANTACID EX-STR 750 MG TAB CHEW | 46122-0007-41 | 0.03219 | EACH | 2025-06-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Antacids Market Analysis and Price Projections for Antacid EX-STR
Introduction to the Antacids Market
The global antacids market is experiencing significant growth, driven by increasing cases of gastrointestinal diseases such as gastroesophageal reflux disease (GERD) and heartburn. Here, we will delve into the market analysis and price projections for antacids, with a focus on the Extra Strength (EX-STR) segment.
Market Size and Growth Projections
The global antacids market is anticipated to grow substantially over the next few years. As of 2023, the market size was estimated at USD 6,810.11 million and is expected to reach USD 8,194.33 million by 2028, registering a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period[1].
By 2034, the market is projected to expand further, reaching a value of USD 10.33 billion from USD 7.47 billion in 2024, with a CAGR of 3.30% from 2024 to 2034[4].
Impact of COVID-19 on the Antacids Market
The COVID-19 pandemic had a dual impact on the antacids market. Initially, it led to production disruptions and labor shortages, resulting in higher prices. However, the pandemic also increased the demand for antacids and other gastrointestinal medications, particularly as these medications were found to enhance the clinical outcomes of COVID-19 patients. For instance, antacid therapy was crucial in managing acidosis in COVID-19 patients, which suggested a positive feedback loop where SARS-CoV-2 infection-induced acidosis enhanced the infection itself[1].
Regional Market Analysis
The antacids market is geographically diverse, with different regions contributing significantly to the overall market size. Europe led the market in 2016 with a 36.9% share and is expected to continue growing at a CAGR of 3.2% from 2017 to 2025. This growth is attributed to the increasing cases of gastrointestinal diseases and the advanced therapeutic and diagnostic facilities available in the region. The rise in online pharmacies and the e-commerce sector also fuels the growth in Europe[5].
Product Segmentation and Extra Strength Antacids
The antacids market is segmented based on drug class and formulation type. Extra Strength (EX-STR) antacids are a popular segment within this market, known for their higher efficacy in providing quick relief from heartburn and acid reflux.
Examples of Extra Strength Antacids
- Tums Extra Strength Antacid Smoothies: These are chewable tablets available in various flavors and are highly rated for their effectiveness[2].
- Gaviscon Extra Strength Antacid: Available in both tablet and liquid forms, Gaviscon is another well-regarded brand in the extra strength category[2].
Pricing Trends and Projections
The pricing of antacids, including extra strength variants, can vary based on the brand, formulation, and region. Here are some general pricing trends:
- Current Pricing: Extra strength antacids are generally priced between $5 to $10 for a pack of 60 to 160 tablets, depending on the brand and retailer[2].
- Future Projections: As the market grows, prices may stabilize or slightly increase due to increased demand and production costs. However, competition from generic and store-brand options may keep prices in check.
Factors Influencing Market Size and Revenue Estimation
When estimating the market size and revenue for antacids, several factors are considered:
- Incidence and Prevalence of Disease: The rising prevalence of GERD and heartburn significantly impacts the demand for antacids[4].
- Addressable Market Size: This includes the total population vs. the population in target markets, percentage of diagnosed patients, and percentage of patients treated for the disease[3].
- Pricing Studies and Competitive Analysis: These help in understanding the market dynamics and pricing strategies of competitors[3].
- Reimbursement Analysis: The likelihood of reimbursement from key payer groups can influence the market size and revenue[3].
Market Penetration Analysis
Market penetration analysis for antacids involves several steps:
- Segmentation: Identifying segments such as severely, moderately, and mildly affected patients helps in refining penetration and share forecasts[3].
- Historical Penetration: Analyzing the historical penetration of comparable products provides insights into potential market share[3].
- Preference Analysis: Physician interviews and preference share analysis help in understanding the acceptance and potential use of antacids versus competing treatments[3].
Research Methodology
Primary market research, such as structured interviews with physicians and patients, is crucial for determining usage patterns and dependence on pricing. Historical analysis of the impact of order of entry and penetration analysis to understand prescriber concentration and sales force design are also important[3].
Key Takeaways
- The global antacids market is expected to grow significantly, driven by the increasing prevalence of GERD and heartburn.
- Extra Strength antacids are a key segment, offering quick and effective relief.
- Regional markets, especially Europe, are expected to witness substantial growth.
- Pricing trends will be influenced by demand, competition, and production costs.
- Market size and revenue estimation involve detailed analysis of disease prevalence, pricing studies, and competitive analysis.
FAQs
What is the projected growth rate of the global antacids market?
The global antacids market is expected to grow at a CAGR of 3.7% from 2023 to 2028 and at a CAGR of 3.30% from 2024 to 2034[1][4].
How did the COVID-19 pandemic impact the antacids market?
The COVID-19 pandemic initially caused production disruptions and higher prices but later increased demand due to the role of antacids in managing COVID-19-related acidosis[1].
What are the key factors influencing the market size and revenue estimation for antacids?
Key factors include incidence and prevalence of disease, addressable market size, pricing studies, competitive analysis, and reimbursement analysis[3].
Which region is expected to dominate the antacids market?
Europe is expected to continue dominating the market due to increasing cases of gastrointestinal diseases and advanced therapeutic facilities[5].
What is the typical pricing range for extra strength antacids?
Extra strength antacids are generally priced between $5 to $10 for a pack of 60 to 160 tablets, depending on the brand and retailer[2].
Sources
- Mordor Intelligence: Antacids Market Report | Industry Analysis, Size & Forecast Overview
- Target: Extra Strength Antacid
- iHealthcareAnalyst: Revenue Forecasting Techniques for New Pharmaceutical Drugs
- Towards Healthcare: Antacids Market Size, Trends & 3.30% CAGR Growth by 2034
- Transparency Market Research: Antacids Market by Drug Class, Formulation Type & Forecast - 2025
More… ↓
